Anti-aging pill startup Elysium Health inks at least $20 million in Series B funding

0
310



 Elysium Health markets a pill formulated with ingredients it says will keep you feeling young and, according to a source close to the matter and documents obtained by TechCrunch, the startup has closed on $20 million in Series B financing at what we’re told is a $157 million pre-money valuation from ARCH Venture Partners.
Reached for comment, Elysium suggested that our information is… Read More





Source link

ОСТАВЬТЕ ОТВЕТ